Both Novo and Lilly have also had to face off with compounders, who have offered cheaper knock-off versions of weight-loss shots. “We fought and still are fighting against knock-off products,” Doustdar said. Novo did not expect the rise of companies selling what he called “unsafe knock-off products.”